The agency revived an old treatment for cancer patients, unilaterally approving it for a subset of people with autism. Experts worry that the narrower scope will get lost in the hype.
from NYT > Health https://ift.tt/Srwi9FC
Subscribe to:
Post Comments (Atom)
Rose
0 comments:
Post a Comment